Jun 13
|
3 Healthcare Stocks with Questionable Fundamentals
|
Jun 12
|
Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease
|
Jun 12
|
Moderna explores outside financing for vaccine trials, shares dip
|
Jun 12
|
Novavax's COVID-Flu Combo Shot Shows Strong Immune Response
|
Jun 12
|
Is it Time to Dump Your Shares of Moderna?
|
Jun 11
|
Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel
|
Jun 11
|
Moderna to Present at Upcoming Barclays Speaking the Science Call Series on June 16, 2025
|
Jun 10
|
Vaccine Stocks Mixed After RFK Jr. Fires CDC's Entire Vaccine Committee
|
Jun 10
|
Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.’s Firing of Vaccine Advisors.
|
Jun 10
|
BlackRock, Goldman Scale Up Tax Trades in $3 Trillion SMA Boom
|
Jun 10
|
RFK Jr. removes CDC vaccine panel members: What to know
|
Jun 6
|
S&P 500 Gains and Losses Today: Lululemon Stock Falls as Forecasts Reflect Consumer Caution
|
Jun 6
|
DraftKings, Teladoc, Rush Street Interactive, Moderna, and Avis Budget Group Shares Are Soaring, What You Need To Know
|
Jun 6
|
Challenges pharma companies face in push into US manufacturing
|
Jun 6
|
Why Is Mirum Pharmaceuticals (MIRM) Down 1.3% Since Last Earnings Report?
|
Jun 5
|
Why Is Denali Therapeutics (DNLI) Up 0.7% Since Last Earnings Report?
|
Jun 4
|
Why Is Axsome (AXSM) Down 1.8% Since Last Earnings Report?
|
Jun 4
|
Down 80%, Should You Buy the Dip on Moderna?
|
Jun 3
|
Moderna Secures FDA Nod for Next-Gen COVID-19 Vaccine mNexspike
|
Jun 3
|
Company News for Jun 3, 2025
|